Singapore, Nov. 19 -- INEX Innovate's iGene Laboratory (iGene) has announced a project with Eli Lilly and Company's research unit Lilly Centre for Clinical Pharmacology (LCCP), which conducts early phase clinical trials in healthy participants and patients in Singapore.

Under this collaboration, iGene will perform genotyping analysis as part of LCCP's research screening activities.

Genotyping is a technology that detects variations at specific positions in the human DNA sequence. This variation - the genotype - occurs naturally and is considered a genetic fingerprint of any individual. It is identified as distinct compared to a reference sequence derived from the general population or a defined subgroup, and can differ from the referenc...